{"id":8507,"date":"2004-07-06T10:07:00","date_gmt":"2004-07-06T10:07:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=8507"},"modified":"2022-10-26T10:10:28","modified_gmt":"2022-10-26T10:10:28","slug":"improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/","title":{"rendered":"Improvement of adult Still&#8217;s disease with granulocyte and monocyte adsorption apheresis"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Kanekura+T&amp;cauthor_id=15245543\">T Kanekura<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15245543\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Terasaki+K&amp;cauthor_id=15245543\">K Terasaki<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Higashi+Y&amp;cauthor_id=15245543\">Y Higashi<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Yoshii+N&amp;cauthor_id=15245543\">N Yoshii<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Kawahara+K&amp;cauthor_id=15245543\">K Kawahara<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Maruyama+I&amp;cauthor_id=15245543\">I Maruyama<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Kanzaki+T&amp;cauthor_id=15245543\">T Kanzaki<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Clin Exp Dermatol <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=%22Clin+Exp+Dermatol%22%5Bjour%5D&amp;sort_order=desc\"><\/a>2004 Jul;29(4):410-2.\u00a0doi: 10.1111\/j.1365-2230.2004.01502.x.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Adult Still&#8217;s disease is characterized by a high spiking fever, transient skin rash, and polyarthralgia. Joint pain is one of the major complaints and is often intractable. We assessed the efficacy of granulocyte and monocyte adsorption apheresis (GCAP) therapy for treating arthralgia in adult Still&#8217;s disease. A 33-year-old woman with adult Still&#8217;s disease who suffered from recalcitrant arthralgia resistant to systemic corticosteroids was treated with GCAP therapy. She underwent five GCAP treatments at 5-day intervals. Her joint pain responded dramatically to the GCAP therapy, suggesting that GCAP may be useful for treating adult Still&#8217;s disease. We present a detailed description of the patient and this novel therapy.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15245543\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/15245543\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>T Kanekura\u00a01,\u00a0K Terasaki,\u00a0Y Higashi,\u00a0N Yoshii,\u00a0K Kawahara,\u00a0I Maruyama,\u00a0T Kanzaki Clin Exp Dermatol 2004 Jul;29(4):410-2.\u00a0doi: 10.1111\/j.1365-2230.2004.01502.x. Adult Still&#8217;s disease is characterized by a high spiking fever, transient skin rash, and polyarthralgia. Joint pain is one of the major complaints and is often intractable. We assessed the efficacy of granulocyte and monocyte adsorption apheresis (GCAP) therapy for treating [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[663,631,424,675,677,679,135],"class_list":["post-8507","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-adult-stills-disease","scientific_tags-case","scientific_tags-gma","scientific_tags-join-pain","scientific_tags-polyarthralgia","scientific_tags-skin-rash","scientific_tags-steroid-refractory"],"acf":{"sc_authors":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Improvement of adult Still&#039;s disease with granulocyte and monocyte adsorption apheresis - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Improvement of adult Still&#039;s disease with granulocyte and monocyte adsorption apheresis - Adacyte\" \/>\n<meta property=\"og:description\" content=\"T Kanekura\u00a01,\u00a0K Terasaki,\u00a0Y Higashi,\u00a0N Yoshii,\u00a0K Kawahara,\u00a0I Maruyama,\u00a0T Kanzaki Clin Exp Dermatol 2004 Jul;29(4):410-2.\u00a0doi: 10.1111\/j.1365-2230.2004.01502.x. Adult Still&#8217;s disease is characterized by a high spiking fever, transient skin rash, and polyarthralgia. Joint pain is one of the major complaints and is often intractable. We assessed the efficacy of granulocyte and monocyte adsorption apheresis (GCAP) therapy for treating [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-26T10:10:28+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/\",\"name\":\"Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2004-07-06T10:07:00+00:00\",\"dateModified\":\"2022-10-26T10:10:28+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/","og_locale":"de_DE","og_type":"article","og_title":"Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis - Adacyte","og_description":"T Kanekura\u00a01,\u00a0K Terasaki,\u00a0Y Higashi,\u00a0N Yoshii,\u00a0K Kawahara,\u00a0I Maruyama,\u00a0T Kanzaki Clin Exp Dermatol 2004 Jul;29(4):410-2.\u00a0doi: 10.1111\/j.1365-2230.2004.01502.x. Adult Still&#8217;s disease is characterized by a high spiking fever, transient skin rash, and polyarthralgia. Joint pain is one of the major complaints and is often intractable. We assessed the efficacy of granulocyte and monocyte adsorption apheresis (GCAP) therapy for treating [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/","og_site_name":"Adacyte","article_modified_time":"2022-10-26T10:10:28+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/","name":"Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2004-07-06T10:07:00+00:00","dateModified":"2022-10-26T10:10:28+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/improvement-of-adult-stills-disease-with-granulocyte-and-monocyte-adsorption-apheresis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/8507","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=8507"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=8507"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}